Atlas Trials

A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients

Clinical trial NCT01478607 · COMPLETED

Trial details

NCT number
NCT01478607
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Painful Diabetic Peripheral Neuropathy (PDPN)
Start date
2011-11-01
Primary completion
2014-02-01
Enrollment
468

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.